CoChat

Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences

Open access
Brázdová, Marie, Quante, Timo, Tögel, Lars, Walter, Korden, Loscher, Christine, Tichý, Vlastimil, Činčárová, Lenka, Deppert, Wolfgang, Tolstonog, Genrich V. · 2009 · Nucleic Acids Research
Cited by 72

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Missense point mutations in the TP53 gene are frequent genetic alterations in human tumor tissue and cell lines derived thereof. Mutant p53 (mutp53) proteins have lost sequence-specific DNA binding, but have retained the ability to interact in a structure-selective manner with non-B DNA and to act as regulators of transcription. To identify functional binding sites of mutp53, we established a small library of genomic sequences bound by p53(R273H) in U251 human glioblastoma cells using chromatin immunoprecipitation (ChIP). Mutp53 binding to isolated DNA fragments confirmed the specificity of the ChIP. The mutp53 bound DNA sequences are rich in repetitive DNA elements, which are dispersed over non-coding DNA regions. Stable down-regulation of mutp53 expression strongly suggested that mutp53 binding to genomic DNA is functional. We identified the PPARGC1A and FRMD5 genes as p53(R273H) targets regulated by binding to intronic and intra-genic sequences. We propose a model that attributes the oncogenic functions of mutp53 to its ability to interact with intronic and intergenic non-B DNA sequences and modulate gene transcription via re-organization of chromatin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkn1085

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 71

  1. Soussi, 2005, Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations, Hum. Mutat, 25, 6, 10.1002/humu.20114 · DOI · Paper page
  2. Ma, 2007, Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements, Nucleic Acids Res, 35, 7733, 10.1093/nar/gkm890 · DOI
  3. Ang, 2006, Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains, J. Biol. Chem, 281, 21934, 10.1074/jbc.M604209200 · DOI · Paper page
  4. Gohler, 2005, Mutant p53 proteins bind DNA in a DNA structure-selective mode, Nucleic Acids Res, 33, 1087, 10.1093/nar/gki252 · DOI · Paper page
  5. Kim, 2004, Transcriptional activities of mutant p53: when mutations are more than a loss, J. Cell Biochem, 93, 878, 10.1002/jcb.20271 · DOI · Paper page
  6. Weisz, 2007, Transcription regulation by mutant p53, Oncogene, 26, 2202, 10.1038/sj.onc.1210294 · DOI · Paper page
  7. Chicas, 2000, Mutant p53 forms a complex with Sp1 on HIV-LTR DNA, Biochem. Biophys. Res. Commun, 279, 383, 10.1006/bbrc.2000.3965 · DOI
  8. Xu, 2002, Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells, EMBO J, 21, 4081, 10.1093/emboj/cdf413 · DOI
  9. Matas, 2001, Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis, EMBO J, 20, 4163, 10.1093/emboj/20.15.4163 · DOI
  10. Frazier, 1998, Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain, Mol. Cell Biol, 18, 3735, 10.1128/MCB.18.7.3735 · DOI · Paper page
  11. Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
  12. Liu, 2001, Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein, J. Mol. Biol, 313, 711, 10.1006/jmbi.2001.5082 · DOI
  13. Istrail, 2005, Logic functions of the genomic cis-regulatory code, Proc. Natl Acad. Sci. USA, 102, 4954, 10.1073/pnas.0409624102 · DOI · Paper page
  14. de Laat, 2003, Spatial organization of gene expression: the active chromatin hub, Chromosome Res, 11, 447, 10.1023/A:1024922626726 · DOI · Paper page
  15. Gaszner, 2006, Insulators: exploiting transcriptional and epigenetic mechanisms, Nat. Rev. Genet, 7, 703, 10.1038/nrg1925 · DOI · Paper page
  16. Gluch, 2008, Scaffold/matrix attachment regions (S/MARs): relevance for disease and therapy, Handb. Exp. Pharmacol, 186, 67, 10.1007/978-3-540-72843-6_4 · DOI
  17. Razin, 1995, Specificity and functional significance of DNA interaction with the nuclear matrix: new approaches to clarify the old questions, Int. Rev. Cytol, 162B, 405
  18. Berezney, 1995, The nuclear matrix: a structural milieu for genomic function, Int. Rev. Cytol, 162A, 1
  19. Bode, 2006, Correlations between scaffold/matrix attachment region (S/MAR) binding activity and DNA duplex destabilization energy, J. Mol. Biol, 358, 597, 10.1016/j.jmb.2005.11.073 · DOI
  20. Koga, 2000, Identification of genomic DNA sequences bound by mutant p53 protein (Gly245–>Ser) in vivo, Oncogene, 19, 4178, 10.1038/sj.onc.1203745 · DOI
  21. Deppert, 1996, Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions, J. Cell Biochem, 62, 172, 10.1002/(SICI)1097-4644(199608)62:2<172::AID-JCB5>3.0.CO;2-P · doi:10.1002/(sici)1097-4644(199608)62:2<172::aid-jcb5>3.0.co;2-p
  22. Weissker, 1992, Specific and complex interactions of murine p53 with DNA, Oncogene, 7, 1921
  23. Will, 1998, High affinity MAR-DNA binding is a common property of murine and human mutant p53, J. Cell Biochem, 69, 260, 10.1002/(SICI)1097-4644(19980601)69:3<260::AID-JCB4>3.0.CO;2-P · DOI
  24. Will, 1998, Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing, Proc. Natl Acad. Sci. USA, 95, 13681, 10.1073/pnas.95.23.13681 · DOI · Paper page
  25. Orlando, 1997, Analysis of chromatin structure by in vivo formaldehyde cross-linking, Methods, 11, 205, 10.1006/meth.1996.0407 · DOI · Paper page
  26. Tolstonog, 2001, Isolation of SDS-stable complexes of the intermediate filament protein vimentin with repetitive, mobile, nuclear matrix attachment region, and mitochondrial DNA sequence elements from cultured mouse and human fibroblasts, DNA Cell Biol, 20, 531, 10.1089/104454901317094954 · DOI
  27. Brummelkamp, 2002, A system for stable expression of short interfering RNAs in mammalian cells, Science, 296, 550, 10.1126/science.1068999 · DOI · Paper page
  28. Chen, 2005, Real-time quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res, 33, e179, 10.1093/nar/gni178 · DOI · Paper page
  29. Kent, 2002, BLAT–the BLAST-like alignment tool, Genome Res, 12, 656, 10.1101/gr.229202 · DOI · Paper page
  30. Halees, 2004, PromoSer: improvements to the algorithm, visualization and accessibility, Nucleic Acids Res, 32, W191, 10.1093/nar/gkh433 · DOI
  31. Hackl, 2005, Molecular processes during fat cell development revealed by gene expression profiling and functional annotation, Genome Biol, 6, R108, 10.1186/gb-2005-6-13-r108 · DOI · Paper page
  32. Singh, 1997, Mathematical model to predict regions of chromatin attachment to the nuclear matrix, Nucleic Acids Res, 25, 1419, 10.1093/nar/25.7.1419 · DOI · Paper page
  33. Thomas-Chollier, 2008, RSAT: regulatory sequence analysis tools, Nucleic Acids Res, 36, W119, 10.1093/nar/gkn304 · DOI · Paper page
  34. Grillo, 2003, PatSearch: A program for the detection of patterns and structural motifs in nucleotide sequences, Nucleic Acids Res, 31, 3608, 10.1093/nar/gkg548 · DOI · Paper page
  35. Brazdova, 2002, Role of tumor suppressor p53 domains in selective binding to supercoiled DNA, Nucleic Acids Res, 30, 4966, 10.1093/nar/gkf616 · DOI
  36. Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc, 3, 1101, 10.1038/nprot.2008.73 · DOI · Paper page
  37. Britanova, 2005, Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS, Eur. J. Neurosci, 21, 658, 10.1111/j.1460-9568.2005.03897.x · DOI · Paper page
  38. Nickerson, 1997, The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus, Proc. Natl Acad. Sci. USA, 94, 4446, 10.1073/pnas.94.9.4446 · DOI · Paper page
  39. He, 2008, Chromatin organization and nuclear microenvironments in cancer cells, J. Cell Biochem, 104, 2004, 10.1002/jcb.21485 · DOI
  40. Carter, 2008, Transcription factories, Biochem. Soc. Trans, 36, 585, 10.1042/BST0360585 · DOI · Paper page
  41. Stein, 2004, Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation, J. Cell Biochem, 91, 287, 10.1002/jcb.10777 · DOI
  42. van Wijnen, 1993, Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1, Biochemistry, 32, 8397, 10.1021/bi00084a003 · DOI · Paper page
  43. Guo, 1995, The nuclear matrix protein NMP-1 is the transcription factor YY1, Proc. Natl Acad. Sci. USA, 92, 10526, 10.1073/pnas.92.23.10526 · DOI · Paper page
  44. Koutsodontis, 2005, Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis, Biochem. J, 389, 443, 10.1042/BJ20041980 · DOI · Paper page
  45. Sui, 2004, Yin Yang 1 is a negative regulator of p53, Cell, 117, 859, 10.1016/j.cell.2004.06.004 · DOI · Paper page
  46. Guelen, 2008, Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions, Nature, 453, 948, 10.1038/nature06947 · DOI · Paper page
  47. Luderus, 1992, Binding of matrix attachment regions to lamin B1, Cell, 70, 949, 10.1016/0092-8674(92)90245-8 · DOI
  48. Hearnes, 2005, Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators, Mol. Cell Biol, 25, 10148, 10.1128/MCB.25.22.10148-10158.2005 · DOI · Paper page
  49. Greig, 1992, Beta satellite DNA: characterization and localization of two subfamilies from the distal and proximal short arms of the human acrocentric chromosomes, Genomics, 12, 573, 10.1016/0888-7543(92)90450-7 · DOI
  50. Eichler, 1998, Complex beta-satellite repeat structures and the expansion of the zinc finger gene cluster in 19p12, Genome Res, 8, 791, 10.1101/gr.8.8.791 · DOI · Paper page
  51. Sbisa, 2007, p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data, BMC Bioinformatics, 8, S20, 10.1186/1471-2105-8-S1-S20 · DOI · Paper page
  52. Frank-Kamenetskii, 1995, Triplex DNA structures, Annu. Rev. Biochem, 64, 65, 10.1146/annurev.bi.64.070195.000433 · DOI · Paper page
  53. Mazur, 1999, Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain, J. Mol. Biol, 292, 241, 10.1006/jmbi.1999.3064 · DOI
  54. Palecek, 2004, Enhancement of p53 sequence-specific binding by DNA supercoiling, Oncogene, 23, 2119, 10.1038/sj.onc.1207324 · DOI
  55. Reczek, 2003, Multiple response elements and differential p53 binding control Perp expression during apoptosis, Mol. Cancer Res, 1, 1048
  56. Zauberman, 1995, A functional p53-responsive intronic promoter is contained within the human mdm2 gene, Nucleic Acids Res, 23, 2584, 10.1093/nar/23.14.2584 · DOI · Paper page
  57. Joerger, 2005, Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations, J. Biol. Chem, 280, 16030, 10.1074/jbc.M500179200 · DOI · Paper page
  58. Hinow, 2006, The DNA binding activity of p53 displays reaction-diffusion kinetics, Biophys. J, 91, 330, 10.1529/biophysj.105.078303 · DOI
  59. Mueller, 2008, Evidence for a common mode of transcription factor interaction with chromatin as revealed by improved quantitative fluorescence recovery after photobleaching, Biophys. J, 94, 3323, 10.1529/biophysj.107.123182 · DOI · Paper page
  60. Xiao, 1994, Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53, Mol. Cell Biol, 14, 7013, 10.1128/MCB.14.10.7013 · DOI · Paper page
  61. Jurka, 2007, Repetitive sequences in complex genomes: structure and evolution, Annu. Rev. Genomics Hum. Genet, 8, 241, 10.1146/annurev.genom.8.080706.092416 · DOI · Paper page
  62. Zuckerkandl, 2007, Combinatorial epigenetics, ‘junk DNA’, and the evolution of complex organisms, Gene, 390, 232, 10.1016/j.gene.2006.12.001 · DOI
  63. Hanke, 1995, Repetitive Alu elements form a cruciform structure that regulates the function of the human CD8 alpha T cell-specific enhancer, J. Mol. Biol, 246, 63, 10.1006/jmbi.1994.0066 · DOI
  64. Howell, 1997, The ability to form intrastrand tetraplexes is an evolutionarily conserved feature of the 3′ end of L1 retrotransposons, Mol. Biol. Evol, 14, 144, 10.1093/oxfordjournals.molbev.a025747 · DOI
  65. Li, 2008, Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm, PLoS Biol, 6, e27, 10.1371/journal.pbio.0060027 · DOI · Paper page
  66. Jackson, 2003, The principles of nuclear structure, Chromosome Res, 11, 387, 10.1023/A:1024954123092 · DOI
  67. Cremer, 2001, Chromosome territories, nuclear architecture and gene regulation in mammalian cells, Nat. Rev. Genet, 2, 292, 10.1038/35066075 · DOI · Paper page
  68. Jiang, 2003, Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes, Int. J. Cancer, 106, 752, 10.1002/ijc.11302 · DOI · Paper page
  69. Olivier, 2006, The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer, Clin. Cancer Res, 12, 1157, 10.1158/1078-0432.CCR-05-1029 · DOI · Paper page
  70. Bossi, 2008, Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy, Cell Cycle, 7, 1870, 10.4161/cc.7.12.6161 · DOI · Paper page
  71. Heinlein, 2008, Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis, Int. J. Cancer, 122, 1701, 10.1002/ijc.23317 · DOI · Paper page

Cited by

See all 72

Metadata

Authors
Brázdová, M., Quante, T., Tögel, L., Walter, K., Loscher, C., Tichý, V., Činčárová, L., Deppert, W., & Tolstonog, G. V.
Venue
Nucleic Acids Research
Published
2009-01-12
Volume
37
Issue
5
Pages
1486-1500
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2010363079
Cited by
72
References
9
FWCI
1.34
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences. https://app.cochat.ai/papers/10.1093/nar/gkn1085
The paper
Brázdová, M., Quante, T., Tögel, L., Walter, K., Loscher, C., Tichý, V., Činčárová, L., Deppert, W., & Tolstonog, G. V. (2009). Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences. Nucleic Acids Research. https://doi.org/10.1093/nar/gkn1085

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.